This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of July 2024. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.
| Item | Value |
|---|---|
| Country | |
| Wikipedia page | https://en.wikipedia.org/wiki/Global_HIV_Vaccine_Enterprise |
| Cause area | Count | Median | Mean | Minimum | 10th percentile | 20th percentile | 30th percentile | 40th percentile | 50th percentile | 60th percentile | 70th percentile | 80th percentile | 90th percentile | Maximum |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | 8 | 500,000 | 2,926,505 | -3,500,000 | 0 | 109,226 | 400,000 | 500,000 | 500,000 | 749,216 | 749,999 | 4,403,600 | 20,000,000 | 20,000,000 |
| Global health | 8 | 500,000 | 2,926,505 | -3,500,000 | 0 | 109,226 | 400,000 | 500,000 | 500,000 | 749,216 | 749,999 | 4,403,600 | 20,000,000 | 20,000,000 |
| Donor | Total | 2017 | 2016 | 2013 | 2012 | 2010 | 2009 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation (filter this donee) | 23,412,041.00 | 749,999.00 | 749,216.00 | 500,000.00 | -3,500,000.00 | 400,000.00 | 109,226.00 | 20,000,000.00 | 4,403,600.00 |
| Total | 23,412,041.00 | 749,999.00 | 749,216.00 | 500,000.00 | -3,500,000.00 | 400,000.00 | 109,226.00 | 20,000,000.00 | 4,403,600.00 |
There are no documents associated with this donee.
Graph of top 10 donors (for donations with known year of donation) by amount, showing the timeframe of donations
| Donor | Amount (current USD) | Amount rank (out of 8) | Donation date | Cause area | URL | Influencer | Notes |
|---|---|---|---|---|---|---|---|
| Bill and Melinda Gates Foundation | 749,999.00 | 3 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research; Aid type: Other technical assistance. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 749,216.00 | 4 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene an international conference to discuss and share broadly the latest HIV vaccine, microbicide, and ARV-based prevention research; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 500,000.00 | 5 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to convene researchers, advocates, clinicians, policy makers, private sector partners and public health experts in South Africa to share and discuss the latest research in ARV-based prevention, vaccines and related areas of HIV prevention; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | -3,500,000.00 | 8 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide an operational support grant to the Global HIV Vaccine Enterprise. Operational Support to the Enterprise Secretariat. Investment start date: 10/1/2007 to end date: 12/31/2017. Grantee name: Global HIV Vaccine Enterprise; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 400,000.00 | 6 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | for conference support. AIDS Vaccine 2010. Investment start date: 4/13/2010 to end date: 1/31/2011. Grantee name: Global HIV Vaccine Enterprise; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 109,226.00 | 7 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to support the AIDS Vaccine 2009 conference. AIDS vaccine 2009 conference in Paris. Investment start date: 8/1/2009 to end date: 1/31/2010. Grantee name: Global HIV Vaccine Enterprise; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 20,000,000.00 | 1 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | to provide an operational support grant to the Global HIV Vaccine Enterprise. Operational Support to the Enterprise Secretariat. Investment start date: 10/1/2007 to end date: 12/31/2017. Grantee name: Global HIV Vaccine Enterprise; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified. | |
| Bill and Melinda Gates Foundation | 4,403,600.00 | 2 | Global health/STD control including HIV/AIDS | https://iatiregistry.org/publisher/bmgf | -- | for general operating support. Operational support grant-Enterprise Secretariat. Investment start date: 6/1/2006 to end date: 6/1/2007. Grantee name: Global HIV Vaccine Enterprise; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified. |